Singapore, May 14 -- Administered through theNational Health and Medical Research Council's (NHMRC) Clinical Trials and Cohort Studiesgrant scheme in Australia, 22 teams will be supported to discover relevant and implementable findings for the benefit of human health, including improvements to healthcare practice and policy.

Over $3 million will be awarded to Associate Professor Alexander Van Akkooi who is aiming to provide a less invasive treatment option for patients with stage III melanoma without compromising outcomes.

Based out of the Melanoma Institute Australia (MIA), Associate Professor van Akkooi and a team of researchers at MIA, including 2024 Joint Australian of the Year Professor Georgina Long, will lead a clinical trial to ...